| P2093 | author name string | P J Loehrer | |
| | T Kuzel | |
| | J Manola | |
| | P A Burch | |
| | E L Weinshel | |
| | R S Witte | |
| P2860 | cites work | Toxicity and response criteria of the Eastern Cooperative Oncology Group | Q29619399 |
| | Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy | Q33495774 |
| | Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan | Q33497327 |
| | Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer | Q33500776 |
| | Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer | Q33501053 |
| | Chemotherapy for advanced urothelial cancer. | Q40185869 |
| | A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study | Q40731377 |
| | The current status of camptothecin analogues as antitumor agents | Q40851253 |
| | Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma | Q40905847 |
| | Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse | Q43419722 |
| | An Eastern Cooperative Oncology Group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma. | Q54214610 |
| | Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. | Q54418734 |
| | Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors | Q68032662 |
| P433 | issue | 2 | |
| P921 | main subject | phase II clinical trial | Q42824440 |
| P304 | page(s) | 191-195 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Investigational New Drugs | Q2312231 |
| P1476 | title | Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trial | |
| P478 | volume | 16 | |